Organigram received good news when Nova Scotia’s Court of Appeal, dramatically tightened the scope of the class-action lawsuit against the company over tainted MED sold in 2016.
Torkin Manes Blog, CBC New Brunswick
- Organigram sold MED containing banned pesticides (the source of which the company couldn’t identify), in 2016 and recalled products in 2017.
CBC New Brunswick, Globe and Mail, Equity Guru
- In a decision partially overturning the certification of the class-action suit, the Nova Scotia Court of Appeal found no direct evidence the tainted MED could cause particular adverse health effects.
Financial Post, Mugglehead
- The remaining scope of the class action suit pertains to reimbursements for MED customers who bought products in 2016.
More LP News:
After news broke that RavenQuest BioMed was to lose its final Health Canada license after being yet again locked out of its facilities for non-payment of rent, CEO, president, CFO, and director George Robinson resigned, and the company accused him of taking the company’s financial documents and other paperwork hostage and “holding all records in lieu of pay.” RQBM’s remaining director “sees no prospect for the company’s survival.”
The Deep Dive, Equity Guru